The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia Surveillance
Abstract
Objective: To determine the mortality, hospital stay, and total hospital charges and cost of hospitalization attributable to candidemia by comparing patients with candidemia with control-patients who have otherwise similar illnesses. Prior studies lack broad patient and hospital representation or cost-related information that accurately reflects current medical practices. Design: Our case-control study included case-patients with candidemia and their cost-related data, ascertained from laboratory-based candidemia surveillance conducted among all residents of Connecticut and Baltimore and Baltimore County, Maryland, during 1998 to 2000. Control-patients were matched on age, hospital type, admission year, discharge diagnoses, and duration of hospitalization prior to candidemia onset. Results: We identified 214 and 529 sets of matched case-patients and control-patients from the two locations, respectively. Mortality attributable to candidemia ranged between 19% and 24%. On multivariable analysis, candidemia was associated with mortality (OR, 5.3 for Connecticut and 8.5 for Baltimore and Baltimore County;P< .05), whereas receiving adequate treatment was protective (OR, 0.5 and 0.4 for the two locations, respectively;P< .05). Candidemia itself did not increase the total hospital charges and cost of hospitalization; when treatment status was accounted for, having received adequate treatment for candidemia significantly increased the total hospital charges and cost of hospitalization ($6,000 to $29,000 and $3,000 to $22,000, respectively) and the length of stay (3 to 13 days). Conclusion: Our findings underscore the burden of candidemia, particularly regarding the risk of death, length of hospitalization, and cost associated with treatment (Infect Control Hosp Epidemiol 2005;26:540-547).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Carefully matched, retrospective cohort studies have been undertaken to estimate mortality attributable to candidemia and report rates ranging from 10% to 49%.[10][11][12][13][14][15]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [10]
In the citing paper
“Studies on patients with IC have similarly shown excessive rates of inappropriate initial therapy and even higher mortality than infections caused by bacterial pathogens in the ICU setting.10,14,33,34,[42][43][44][45][46][47]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [10]
In the citing paper
“Estimates from numerous studies suggest the added hospital cost is as much as $40,000 per case.[10][11][12][16][17][18][19][20]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [10]
In the citing paper
“Numerous reports have documented the association between inadequate dosing of antifungals in patients with IC and increased length of hospital stay, health care costs, morbidity, and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [10]
In the citing paper
“In addition, candidemia brings a substantial economic burden, involving, on average, three to 13 days of hospitalization in the US, with total associated costs ranging from $6000 to $29,000 [5].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [5]
Citations
Cites
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Pittet, D. (1994) · JAMA · doi:10.1001/jama.271.20.1598 · Cited by 1,354
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Beck‐Sagué, C. M., Jarvis, W. R., & System, N. N. I. S. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Nosocomial Bloodstream Infection in Critically III Patients
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 946
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Self-citationEpidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species
Jarvis, W. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1526 · Cited by 636
Trends in Infectious Diseases Mortality in the United States
Pinner, R. W. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530270029027 · Cited by 487
Flagged first, then by citations
Research works printed but not linked: 5
- Haddix, 2003, Prevention Effectiveness, 53
- Consumer Price Index
- ChimeData Program
- Health Services Cost Review
- 10.1001/archinte.1995.00430110089009 · DOI · Paper page
Cited by
Sorted by citations
Items 301–400 of 438
Pathan, S. K., Shelar, A. V., Deshmukh, S. U., Khan, F. A. K., Ansari, S. A., Ansari, I. A., Patil, R. B., Arote, R. B., Bhusnure, O. G., Patil, R., et al. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2296604 · Cited by 5
Shin, S. U., Bae, S., Cho, D. J., Lee, A. K., Jeong, H. S., Hwang, S., Kim, S., Kim, M., Kim, S. E., Kim, U. J., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10373-5 · Cited by 5
Sakuma, M., Viens, A. L., Hopke, A. R., Floyd, D. J., Ghebremichael, M. S., Mansour, M. K., & Irimia, D. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf002 · Cited by 5
Massanet, P. L., Corne, P., Conseil, M., Perrigault, P. F., Lachaud, L., Jaber, S., Calvet, B., Jonquet, O., & Reynes, J. (2010) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2010.06.007 · Cited by 5
Antimicrobial Stewardship Management of Infections: Beyond the Costs of Antimicrobials
Goff, D. A., Bauer, K. A. A., & Mangino, J. E. (2012) · Cited by 5
Pharmacoeconomics of antifungal therapy: current considerations
Ashley, E. D. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000399604.68268.79 · Cited by 5
Faridi, A., Amanizadeh, A., Mousavi, S. A. A., Salari, S., Kalantar-Neyestanaki, D., Sharifynia, S., & Afshari, S. A. K. (2022) · Iranian Journal of Microbiology · doi:10.18502/ijm.v14i3.9795 · Cited by 5
Candida massiliensis sp. nov. Isolated from a Clinical Sample
Kabtani, J., Boulanouar, F., Militello, M., Cassagne, C., & Ranque, S. (2023) · Mycopathologia · doi:10.1007/s11046-023-00792-4 · Cited by 5
Risk Factors for Candidaemia in a Malaysian Tertiary Hospital
Tzar, M. N., Norazlah, B., & Shamsul, A. S. (2015) · Sains Malaysiana · doi:10.17576/jsm-2015-4405-13 · Cited by 5
Alışkan, H. E., Ersözlü, E. D., Çolakoğlu, Ş., & Demirbilek, M. (2016) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2016.49369 · Cited by 5
Yacoub, A. T., Moreland, S., Jani, D., Nanjappa, S., Quilitz, R. E., Carraway, S., Sandin, R. L., & Greene, J. N. (2016) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000403 · Cited by 5
The impact of esophageal candidiasis on hospital charges and costs across patient subgroups
Tong, K. B., Murtagh, K. N., Lau, C., & Seifeldin, R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079908x253401 · Cited by 5
Theodore, D., Henneman, A. D., Loo, A. S., Shields, R. K., Eschenauer, G. A., Sobieszczyk, M. E., & Kubin, C. J. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae175 · Cited by 5
Induction of Antifungal Tolerance Reveals Genetic and Phenotypic Changes in Candida glabrata
Chedraoui, C., Fattouh, N., Hachem, S. E., Younes, M., & Khalaf, R. A. (2025) · Journal of Fungi · doi:10.3390/jof11040284 · Cited by 4
Úbeda, A., Vázquez, A. L., & Gil, C. L. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(10)70029-x · Cited by 4
Mohanraj, H., Vinodhini, V. M., & Vajravelu, L. K. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.2.27 · Cited by 7
Aonofriesei, F. (2023) · Microorganisms · doi:10.3390/microorganisms12010051 · Cited by 4
Lodise, T. P., Garey, K. W., Aram, J. A., & Nathanson, B. H. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad703 · Cited by 4
Antifungal Efficacy of Plant Essential Oils Against Candida, Aspergillus and Cryptococcus Species
Kumari, K. M. U., Imam, M. W., & Luqman, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_5 · Cited by 4
Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?
Gedık, H., Şimşek, F., Yıldırmak, T., Kantürk, A., Arica, D. A., Aydın, D., Demirel, N., & Yokuş, O. (2014) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-014-0370-8 · Cited by 4
Candida kruseicolonization in patients with gastrointestinal diseases
Huong, D. T., Zhao, Y., Nguyệt, N. T. M., Loan, T. T., Bình, N. T. T., Thịnh, N. V., Hạnh, N. T. H., Perez-Perez, G. I., & Perlin, D. S. (2013) · Medical Mycology · doi:10.3109/13693786.2013.804215 · Cited by 4
Candidemia: características en los adultos mayores
Díaz, N. A., Farina, J., Herrera, J. C., & Ezcurra, M. C. (2020) · Revista chilena de infectología · doi:10.4067/s0716-10182020000300288 · Cited by 4
Çeşitli örneklerden izole edilen Candidaların tür dağılımı ve antifungal direnç oranları
Savcı, Ü., & Yılmaz, N. (2017) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.340562 · Cited by 4
Invasive candidiasis in critically ill patients
Kaaniche, F. M., Allela, R., Cherif, S., & Algia, N. B. (2016) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2016.11.002 · Cited by 4
Retrospective observation of drug susceptibility ofCandidastrains in the years 1999, 2004, and 2015
Łukaszuk, C. R., Krajewska-Kułak, E., & Kułąk, W. (2017) · PeerJ · doi:10.7717/peerj.3038 · Cited by 4
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., Queiroz‐Telles, F., Salles, M. J. C., da Cunha, C. A., Shikanai‐Yasuda, M. A., Moretti, M. L., & Nucci, M. (2012) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(12)70336-7 · Cited by 4
Bhadade, A. A., Singh, G., Karuna, T., Panthi, M., Beniwal, A., Maurya, A. K., Upadhyay, N., Reddy, V. R., Devgade, A., & Khadanga, S. (2025) · Cureus · doi:10.7759/cureus.97120 · Cited by 3
Chen, X., Nie, P., Chen, X., Liu, C., Wang, G. X., Peng, Y., Luo, S., Chen, T., Zhou, H., Min, X., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1700990 · Cited by 3
Fungal infections—Background to specific fungal species
Sokóvić, M., & Λιάρας, Κ. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815824-1.00002-0 · Cited by 2
Hu, W., Lin, S., Hu, Y., Huang, H., & Lu, P. (2023) · Mycoses · doi:10.1111/myc.13667 · Cited by 3
Pungprasert, T., Dhirachaikulpanich, D., Phutthasakda, W., Tantai, N., Maneeon, S., Nganthavee, V., Atipas, K., Tanpong, S., Krithin, S., Tanglitanon, S., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2023.12.013 · Cited by 3
Maldonado, I., Canigia, L. F., Vivot, W., Domecq, P., Davel, G., & Córdoba, S. B. (2011) · PubMed · doi:10.1590/s0325-75412011000200010 · Cited by 3
The patient with candidemia: Treatment choices and algorithms
Pappas, P. G. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0017-z · Cited by 3
Leitliniengerechte Therapie: Candidämie/invasive Candidiasis
Glöckner, A. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01838.x · Cited by 3
Invasive Fungal Infections in Pediatric Patients: Challenges to Optimal Management
(2010) · The Journal of Pediatrics · doi:10.1016/s0022-3476(10)00057-0 · Cited by 3
Cost of Invasive Fungal Infections in the Era of New Diagnostics and Expanded Treatment Options
Ashley, E. D., Drew, R. H., Johnson, M. D., Danna, R. P., Dabrowski, D., Walker, V., Prasad, M., Alexander, B. D., Papadopoulos, G., & Perfect, J. R. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1124 · Cited by 3
The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis
Zubovskaia, A., & Vázquez, J. A. (2026) · Infection and Drug Resistance · doi:10.2147/idr.s547511 · Cited by 2
Klebsiella pneumoniae Infections in Intensive Care Unit and Risk Factors for Carbapenem Resistance
Yeşilbağ, Z., Şeker, Y. T., Şenoğlu, S., & Hergünsel, G. O. (2021) · Klimik Dergisi/Klimik Journal · doi:10.36519/kd.2021.05 · Cited by 3
Candidemia in a tertiary care hospital: Changing trends
Babu, A., Kshirsagar, D., Thakar, V. H., Dalal, B. A., Modak, M. S., & Kumar, M. (2024) · IP International Journal of Medical Microbiology and Tropical Diseases · doi:10.18231/j.ijmmtd.2024.040 · Cited by 2
Detection of biofilm production in Candida species isolates recovered from bloodstream patients
Pal, J., & Bisht, D. (2016) · International Journal of Biomedical and Advance Research · doi:10.7439/ijbar.v7i5.3077 · Cited by 2
Synthesis and antifungal activities of some benzimidazolyl-chalcones, analogues of chlormidazole
Sissouma, D., Ouattara, M., & Mamidou, W. K. (2015) · Greater South Information System · doi:10.60692/4a82n-qne34 · Cited by 2
Ibrahim, D., Hong, L. S., & Kuppan, N. (2013) · International Journal of Pharma and Bio Sciences · Cited by 2
Factors influencing recovery in patients with hemoblastoses and candidemia
Klyasova, G. A., Блохина, Е. В., Gracheva, A., Кравченко, С. К., Parovichnikova, E. N., Александрович, О. В., Korobova, A. G., Galstyan, G. M., & Kulikov, S. M. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587777-87 · Cited by 2
Efficacy of Prophylactic Fluconazole in Reducing Candidemia in High Risk NICU and PICU Patients
Mohamed, H. E.-S. (2012) · Cited by 2
In Vitro Comparison of the Efficacy of Cumin Extract and Fluconazole Against Candida Strains
Mehdipour, M., Gholizadeh, N., Sadrzadeh‐Afshar, M., Hematpoor, N., Dentist, P. P., Kalaee, P., Dentist, P. P., Hakemi-Vala, M., & Namazi, Z. (2019) · Majallah-i dandānpizishkī. · doi:10.30699/jidai.31.2.98 · Cited by 2
Evaluation of Pulmonary Infiltrate in Febrile Neutropenic Patients of Hematologic Malignancies
Das, C. K., Gogia, A., Kumar, L., Sharma, A., Thulkar, S. P., Xess, I., & Madan, K. (2019) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/ijmpo.ijmpo_39_18 · Cited by 2
Ndoricyimpaye, E. L., Tuyishime, O., Claude, H. J., d’Amour, M. J., Denyse, N., & Rutayisire, R. (2020) · East Africa Science · doi:10.24248/easci-d-19-00003 · Cited by 2
Early-onset candidemia: An increasing problem?*
Corona, A., & Singer, M. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181abf8e6 · Cited by 2
Central venous catheter (CVC) removal for adult patients with candidaemia
Janum, S., & Afshari, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195 · Cited by 2
Echinocandine bei invasiven Candida-Infektionen
Glöckner, A., & Cornely, O. A. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1058-3 · Cited by 2
Inactivation of Candida albicans Biofilm by Radachlorin-Mediated Photodynamic Therapy
Kwon, P. S. (2015) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2015.47.4.273 · Cited by 1
Bhattacharyya, S., Hussain, N., Sarfraz, A., Sengupta, A., Kumar, D., & Singh, S. (2016) · Eastern Journal of Medical Sciences · doi:10.32677/ejms.2016.v01.i02.002 · Cited by 1
Proteins from Kappaphycus alvarezii: Identification by Mass Spectrometry and Antifungal Potential
Souza, P. F. N., Lima, P. G., Filho, N. S. D. S., Mororó, J. L. T., Gomes, F. Í. R., Oliveira, A. C., Malagueta, G. B., Soares, B. M., da Silva, E. L., Castelo‐Branco, D. D. S. C. M., et al. (2025) · Processes · doi:10.3390/pr13051569 · Cited by 2
Joshi, D. N., Archana, M., Gor, N. S., Bhavana, M. V., Adhikary, R., & Shenoy, B. (2025) · EMJ Microbiology & Infectious Diseases · doi:10.33590/emjmicrobiolinfectdis/hkmw5127 · Cited by 1
Jones, M. N., Nigo, M., Casarin, S., Kurian, J., Sanghvi, A., Hsu, E., Jones, S. L., Connor, A. A., Corry, D. B., Arias, C. A., et al. (2025) · Critical Care Medicine · doi:10.1097/ccm.0000000000006963 · Cited by 1
Mellinghoff, S. C., Grossi, A. A., Recanatini, C., Breull-Wierschem, L., Salm, F., Gadebusch-Bondio, M., & Jung, N. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.05.043 · Cited by 1
Cisterna, R., Ezpeleta, G., & Teller, O. (2012) · InTech eBooks · doi:10.5772/32288 · Cited by 1
An update on the pharmacoeconomics of antifungal pharmacotherapy
Wieczorkiewicz, S. M., Jourjy, J., & Danziger, L. H. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0014-x · Cited by 1
Antifungal therapy: current concepts and evidence-based management
Perfect, J. R., & Andes, D. R. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761136 · Cited by 1
Factores de riesgo para infecciones nosocomiales en pediatría
González, A. B., & López, P. (2013) · Univalle Digital Repository (University of Valle) · Cited by 1
When and which fungal pathogens should come to mind in patients with hematological malignancies
Gedık, H., Şimşek, F., Kantürk, A., Aydın, D., Demirel, N., Yokuş, O., & Arica, D. A. (2013) · Cited by 1
Fungal infections in Intensive Care Service of a specialized hospital Adults
Gill, G. (2016) · Revista del Nacional (Itaguá) · doi:10.18004/rdn2015.0007.02.007-014 · Cited by 1
Probiotics in Invasive Candidiasis
Colombo, J., & Arena, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00048-4 · Cited by 1
Yesterday, Today and Tomorrow of Mycology
Gedık, H. (2016) · Medical Mycology Open Access · doi:10.21767/2471-8521.1000e1 · Cited by 1
New Molecular Method for Detection of Candidemia, but Don’t Forget the Blood Cultures
Hawley, H. B. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1101 · Cited by 1
Colovesicular fistula from Candida dubliniensis in an immunocompetent resulting in poor outcome
Rizkalla, C., Ottombrino, J., & Malik, F. (2020) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2020.1760444 · Cited by 1
Das, S. K., Tawde, Y., Singh, S., Chakrabarti, A., Ray, P., Rudramurthy, S. M., Kaur, H., & Ghosh, A. K. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0077 · Cited by 1
Kuzucu, Ç., Yetkin, G., & Çalışkan, A. (2007) · Cited by 1
Traboulsi, R. S. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-17 · Cited by 1
Ahmadi, N., & Davodi, L. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2017.11.009 · Cited by 1
Мирчевска, Г., Pavlova, M. J., Trajkovska-Dokic, E., Cekovska, Z., Jankoska, G., Petrovska, M., & Panovski, N. (2016) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2016.62.01.006 · Cited by 1
Candida Infections in Hematopoietic and Solid Organ Transplant Recipients
Freifeld, A. G., & Kauffman, C. A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_32 · Cited by 1
Blood stream infections with Candida species: a prospective study in a tertiary care center
Divakar, A. (2017) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2017.i12.07 · Cited by 1
Sunny, S., Episcopia, B., Boudourakis, L. D., Xavier, G., & Quale, J. M. (2021) · Surgical Infections · doi:10.1089/sur.2020.380 · Cited by 1
Rodrigues, M. M. (2012) · Cited by 1
Epidemiology of Candidemia in Finland
Poikonen, E. (2011) · Työväentutkimus Vuosikirja · Cited by 1
Evolution of Drug Resistance in Fungi
Hill, J. A., Hoot, S. J., White, T. C., & Cowen, L. E. (2012) · Wiley eBooks · doi:10.1002/9781118308165.ch8 · Cited by 1
Medidas de prevención de la candidiasis invasora en el paciente crítico no neutropénico
Montejo, J. C., Catalán, M., & del Palacio, A. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70010-9 · Cited by 1
Savage, H. P., Bays, D. J., Gonzalez, M. A. F., Bejarano, E. J., Nguyen, H., Masson, H. L. P., de Carvalho, T. P., Santos, R. L., Thompson, G. R., & Bäumler, A. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.17.537218 · Cited by 1
Genetic Insights into the Rheological Phenotype of Candida albicans BiofilmsPreprint
Abriat, C., Huang, L., Sunder, S., Bauman, J. S., Landry, G. A., Mueller, H. R. L., VanEpps, J. S., Solomon, M. J., & Kumar, A. (2026) · Research Square · doi:10.21203/rs.3.rs-8555167/v1 · Cited by 1
Felder, S., Grabe, K., & Mayrhofer, T. (2010) · PharmacoEconomics German Research Articles · doi:10.1007/bf03320766
Colonização por Candida em indivíduos com candidemia
Miranda, L. D. N. (2008) · doi:10.11606/d.5.2008.tde-04042008-153349
Diagnóstico molecular de candidemia mediante PCR semianidada en pacientes críticos
Ospina, W. P., & Cortés, J. A. (2019) · Acta Médica Colombiana · doi:10.36104/amc.2011.1468
Peres, A. R. M. N. (2012) · Americanae (AECID Library)
Wood, C. A., Rajagopalan, S., Shivaprakash, M., Chandwani, S., & Turpin, R. S. (2009) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31819fe424
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment
Bassetti, M., & Mikulska, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03519-7_11
'Relation, association, attribution ...' – the multiple faces of death in critical care medicine
Toussaint, S., & Gerlach, H. (2009) · Critical Care · doi:10.1186/cc7789
Candidemia in the Pediatric Intensive Care Unit: What’s Different from Candidemia in Adults?
Dotis, J., & Roilides, E. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0043-5
RETRACTED ARTICLE: The exocyst in Candida albicans polarized secretion and filamentation
Chavez‐Dozal, A. A., Bernardo, S. M., & Lee, S. A. (2016) · Current Genetics · doi:10.1007/s00294-015-0553-3
Retractedde Paula, A. O. (2011) · Americanae (AECID Library)
Sofair, A. N. (2011) · Narrative Inquiry in Bioethics · doi:10.1353/nib.2011.0040
Self-citationExploring the mechanisms of action of antifungal peptides using Saccharomyces cerevisiae.
Mason, M. L. (2016) · Journal of the Arkansas Academy of Science
Emerging Resistance AmongCandidaSpecies: Trends and Treatment Considerations for Candidemia
Lee, I., & Zaoutis, T. E. (2007) · Infectious disease and therapy · doi:10.3109/9781420017236.012
Update: invasive Pilzinfektionen Diagnose und Therapie in der operativen Intensivmedizin
Anaesthesiologie, K. F., Heidelberg, U., & Briegel, J. (2010)
Boutoille, D., Tattevin, P., Weinbreck, P., Ansart, S., Hutin, P., Leautez-Nainville, S., Raffi, F., Hôtel-Dieu, C., & de Limoges, C. (2009)
Metadata
- Authors
- Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Johns Hopkins University (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Morgan, Juliette
- ORCID
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2005-06
- Volume
- 26
- Issue
- 6
- Pages
- 540-547
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2138648278
- Semantic Scholar
- fbb5a839e0dc3b43795b4bba8e920640a069b23b
- Cited by
- 437
- References
- 26
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 16 · 2023: 15 · 2022: 18 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 10 · 2017: 19 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 26 · 2012: 36
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Infection Control and Hospital Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- candidemia, excess mortality, length of hospital stay, hospital costs, fungemia, Connecticut, Baltimore
- MeSH terms
- Adolescent, Adult, Candidiasis, Child, Child, Preschool, Connecticut, Cross Infection, Female, Humans, Infant, Length of Stay, Male, Middle Aged, Population Surveillance, Baltimore, Multivariate Analysis, Linear Models, Case-Control Studies, Fungemia, Hospital Mortality, Cost of Illness, Age Distribution, Hospital Costs, Hospital Charges
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review